OssDsign AB
Short position disclosed on June 1, 2026.
0.81% of the capital sold short
1 disclosing funds
7 disclosures on record
SE0012570448 ISIN code
Funds holding OssDsign AB Titelia
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Mar 2026May 2026Jul 2026
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| GSA Capital Partners LLP | 0.81% | new | June 1, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 1, 2026 | GSA Capital Partners LLP | 0.81% | still open |
| April 23, 2026 | GSA Capital Partners LLP | 0.70% | still open |
| April 20, 2026 | GSA Capital Partners LLP | 0.69% | still open |
| April 14, 2026 | GSA Capital Partners LLP | 0.70% | still open |
| March 3, 2026 | GSA Capital Partners LLP | 0.60% | still open |
| February 16, 2026 | GSA Capital Partners LLP | 0.50% | still open |
| February 4, 2026 | Citadel Securities (Europe) Limited | 0.53% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
- Elekta AB (publ) 10.19% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Embracer Group AB 5.25% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Dynavox Group AB 4.30% of the capital sold short
- RaySearch Laboratories AB (publ) 4.15% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, OssDsign AB, source Finansinspektionen, data as at June 1, 2026, https://www.quivad.com/action/ossdsign-ab